Skip to content

The Research of Human Cortex Cell Atlas

The Research of Human Cortex Cell Atlas

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04926987
Enrollment
20
Registered
2021-06-15
Start date
2020-06-01
Completion date
2022-12-30
Last updated
2021-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Epilepsy, Trauma, Brain

Keywords

Single-Cell Analysis, aging, epilepsy, trauma brain

Brief summary

In this study, the single-cell transcriptome sequencing technology was used to study the transcriptome differences at the single-cell level in normal human brain, aging human brain, and epileptic brain.

Detailed description

The human brain has about 100 billion cells and makes up neural networks.The abnormal activity of neurons can affect the operation of neural networks, leading to neurological diseases.With the coming of the age of global population aging, neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's have become an increasing burden on human health. Cells are the basic unit of brain. Understanding the mechanism of brain activities includes not only the mechanism of neural network, but also the self-regulation of its basic unit, that is, the regulation of gene expression based on brain activity.The abnormal expression and regulation of genes lead to the abnormal activities of the nervous system.Therefore, studying the regulation mechanism of gene expression at the cellular level is an important way to research brain diseases.The recent development of single-cell RNA-sequencing technology provides a possibility to understand the functioning mechanism of the brain at the cellular level.

Interventions

OTHERbrain tissue single-cell sequencing

Using single-cell sequencing to study the brain tissue single-cell transcriptome difference in aging, epilepsy, and mental disorders

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Craniocerebral injury patients needing operative treatment * Treatment-resistant epilepsy patients needing resection surgery

Exclusion criteria

* Vital signs unstable * Pregnancy * Tumor * Incomplete medical history, imaging and clinical diagnosis

Design outcomes

Primary

MeasureTime frameDescription
single-cell RNA sequencing1 Day of surgerysingle-cell RNA sequencing resultes of brain sample

Countries

China

Contacts

Primary ContactJianmin Zhang, M.D
zjm135@zju.edu.cn86-13805722695

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026